Clinical Trials Directory

Trials / Completed

CompletedNCT06134037

Effects of Aminophylline Bolus on TCI (Target Controlled Infusion) Concentrations at Burst Suppression Occurence

Effects of Aminophylline Bolus on Eleveld and Schnider TCI (Target Controlled Infusion) Concentrations at Start and End of Burst Suppression Occurence and on BIS (Bispectral Index) During the Induction Phase of Total Intravenous Anaesthesia With TCI

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
University of Padova · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers

Summary

Aminophylline is an intravenous drug commonly utilized for asthma. However, some preclinical studies and few case reports and case series have described its effects in lightining the anesthestic plan during Propofol anaesthesia with an intravenous bolus of 4 mg/kg. Authors aimed to compare its effect during accidental episodes of Burst Suppression during the induction phase of total Intravenous Anaesthesia with Target Controlled Infusion (TIVA-TCI) routinely utilized for general anaesthesia in our hospital.

Detailed description

Aminophylline is an intravenous drug commonly utilized for asthma. However, some preclinical studies and few case reports and case series have described its utility in decrease the timing of return of consciousness after Propofol anaesthesia with an intravenous bolus of 4 mg/kg, and also to lightining the anestetic plan (increase in Bipectral Index - BIS- values). Authors aimed to compare its effect during accidental Burst Suppression episodes during the induction of total Intravenous Anasethesia with Target Controlled Infusion (TIVA-TCI) routinely utilized for general anaesthesia in our hospital, with Eleveld Pharmacokinetic/Pharmacodynamic-PK/PD model). The timing and relative Concentration of Propofol (CeP) from the start to the end of Burst suppression episodes with or without aminophylline bolus deliveres as soon as detected were taken into account.

Conditions

Interventions

TypeNameDescription
DRUGAminophyllinePatients will be observationally included in the Aminophylline or not Aminiophylline group depending on anesthesiologist's discretion.

Timeline

Start date
2023-11-12
Primary completion
2024-02-28
Completion
2024-03-15
First posted
2023-11-18
Last updated
2024-04-25

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06134037. Inclusion in this directory is not an endorsement.